OncologySTAT, a subscription-free professional oncology portal from STM publisher Elsevier, Netherlands, commemorated its 12,000th registered user.
Backed by the support of major healthcare and pharmaceutical companies, OncologySTAT has emerged as one of the most trusted and trafficked professional websites in the growing field of cancer care. Since its launch in September 2007, the site has attracted more than 12,000 registrants, nearly 70 percent of who are physicians or healthcare professionals involved in cancer care, as well as more than 80,000 unique visitors and one million page views. More than 2,200 of OncologySTAT's registered users are U.S.-based oncologists, representing a 20 percent-plus penetration of the U.S. hematology/oncology physician audience.
The portal provides instant access to multiple professional cancer resources, including journals, books, drug monographs, news and databases - in a single online location. In addition, the site is newly certified by the Health on the Net Foundation (HON), a non-profit, non-governmental organisation accredited to the Economic and Social Council (ECOSOC) of the United Nations that promotes and guides the deployment of useful and reliable online medical and health information, and its appropriate and efficient use.
Upon registering, OncologySTAT users can search and download current oncology-related, peer-reviewed articles from more than 100 Elsevier journals or stay informed and up-to-date through features such as daily industry news and regulatory updates, a comprehensive chemotherapy regimens database, professional drug and interaction databases, and weekly summaries of top oncology research findings from over 50 publications. All site content is organised by 29 cancer types, enabling oncologists to instantly access the latest news and scientific updates pertaining to their specialty.
The OncologySTAT advisory board includes 10 of the most influential names in oncology, including two past-presidents of the American Society of Clinical Oncology (ASCO). The editorial team is led by Dr. Schwartzberg, and includes a team of medical oncologists, professional medical writers and oncology fellows.